Pliva receives FDA approval for generic Celexa

New York, Nov. 3 - Pliva dd said it received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Citalopram Hydrobromide tablets 10 mg, 20 mg and 40 mg.

Citalopram Hydrobromide is the AB-rated generic equivalent of Forest Laboratories' Celexa. It is a type of selective serotonin reuptake inhibitors, used for the treatment of depression.

The approval is for Pliva's Pliva, Inc. U.S. generics subsidiary, based in East Hanover, N.J.

Pliva is a Zagreb, Croatia, a pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.